A new rice breeding method: CRISPR/Cas9 system editing of the <i>Xa13</i> promoter to cultivate transgene‐free bacterial blight‐resistant rice
2019 · Plant Biotechnology Journal · 153 citations
https://doi.org/10.1111/pbi.13217
C
Chang‐Yan Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
127
Papers
2.3K
Citations
26
h-index
52
i10-index
Chang‐Yan Li is an academic researcher from Tianjin University. The author has contributed to research in topics: Liver physiology and pathology & Inflammasome and immune disorders & Pancreatic function and diabetes. The author has an h-index of 26, co-authored 108 publications.
ORCID: 0000-0001-9959-1661Papers by this author
worksGinsenoside Rb1 attenuates cardiomyocyte apoptosis induced by myocardial ischemia reperfusion injury through mTOR signal pathway
2020 · Biomedicine & Pharmacotherapy · 57 citations
https://doi.org/10.1016/j.biopha.2020.109913
BRISC is required for optimal activation of NF-κB in Kupffer cells induced by LPS and contributes to acute liver injury
2023 · Cell Death and Disease · 26 citations
https://doi.org/10.1038/s41419-023-06268-z
Toll-like receptor 5-mediated signaling enhances liver regeneration in mice
2021 · Military Medical Research · 20 citations
https://doi.org/10.1186/s40779-021-00309-4
tBHQ attenuates podocyte injury in diabetic nephropathy by inhibiting NADPH oxidase-derived ROS generation via the Nrf2/HO-1 signalling pathway
2022 · Heliyon · 11 citations
https://doi.org/10.1016/j.heliyon.2022.e10515
Notoginsenoside R1 can inhibit the interaction between FGF1 and VEGFA to retard podocyte apoptosis
2023 · BMC Endocrine Disorders · 5 citations
https://doi.org/10.1186/s12902-023-01402-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat